Navigation Links
AMICAS Reports Financial Results for the Fourth Fiscal Quarter and Year Ended December 31, 2008
Date:2/25/2009

icenses, services, hardware, and maintenance/support.

                      Condensed Consolidated Balance Sheets
                                   (Unaudited)
                         (in thousands, except share data)

                                                 December 31,   December 31,
                                                     2008           2007
    Assets
    Current assets:
       Cash and cash equivalents                     $7,366         $8,536
       Marketable securities                         47,627         67,071
       Accounts receivable, net of
        allowances of $158 and $231,
        respectively                                 10,224         10,483
       Prepaid expenses and other current
        assets                                        2,261          2,931
    Total current assets                             67,478         89,021

    Property and equipment, less
     accumulated depreciation and
     amortization of $7,495 and $6,848,
     respectively                                       965          1,186
    Goodwill                                              -         27,313
    Acquired/developed software, less
     accumulated amortization of $10,195
     and $7,992, respectively                         5,805          8,008
    Other intangible assets, less
     accumulated amortization of $2,144
     and $1,742, respectively                         1,256          1,658
    Other assets                                      1,594          1,255
    Total Assets                                    $77,098       $128,441

    Liabilities and stockholders' equity
       Current liabilities:
        Accounts payable and accrued expenses        $4,156         $7,094
        Accrued employee compensation and
         benefits                                     1,611          1,451
        Deferred revenue                             14,657         1
'/>"/>
SOURCE AMICAS, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. AMICAS Announces Definitive Agreement to Acquire Emageon Inc.
2. AMICAS Mourns the Passing of Board Member Dr. Phillip Berman
3. AMICAS Schedules Fourth Quarter and 2008 Year End Earnings Results Conference Call
4. AMICAS Showcases Comprehensive Image and Information Management Solution Suite at RSNA
5. Radiology Associates, P.A. Chooses AMICAS
6. AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008
7. Medical Diagnostic Imaging Group Chooses AMICAS
8. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2008
9. AMICAS Schedules Second Quarter Earnings Call
10. AMICAS Focuses on the Future of Radiology IT at SIIM 2008
11. AMICAS Schedules First Quarter 2008 Earnings Call

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)..., 3D Global Solutions is ... program managing the proposal effort for ReSound ... VA Digital Hearing Aid contract. The award includ...the Department of Defense and other federal agenci...) November 8, 2009 -- 3D Global Solutions is pleas...
(Date:11/8/2009)..., "One victory does not mean the battle is w...Nov. 7 In a vote of 240...-Lipinski-Smith Amendment to prohibit abortion man...loor. ,, Americans United for Life Action Presi...e of this amendment is a victory for the pro-life ...
(Date:11/8/2009)..., WASHINGTON, Nov. 8 /PRNewswire-USNewswire/ ...ry, Director, Operation Rescue Insurrecta Nex. ,...ountry have been fighting to keep child-killing by...,, Mr. Terry states: "This is a great first ste...- but we have a lot of fighting ahead of us. Our r...
(Date:11/7/2009)..., WASHINGTON, Nov. 7 /PRNewswire-USNewswire/ ...ealth Insurance Plans (AHIP), released the followi...,, "Health plans strongly support comprehensive...is discussion by proposing a complete overhaul of ...r, we proposed guaranteed coverage, elimination of...
(Date:11/7/2009)..., HOUSTON, Nov. 7 Calling thi...ociation (AMA), the AMA President J. James Rohack,... physicians from all state and medical specialty s...olicy-making meeting, where health system reform w...com.com/cgi-bin/prnh/20081209/AMALOGO ) ,, "O...
Breaking Medicine News(10 mins):Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2Health News:AHIP Statement on House Passage of H.R. 3962 2Health News:AMA President Kicks Off AMA Meeting Focused on Health Reform 2
...5 Medarex, Inc.,(Nasdaq: MEDX ) and Bristol-Myer...t, after meeting with the U.S. Food and Drug Admin...ogics License Application (BLA) submission for,ipi...to further demonstrate the benefit of ipilimumab. ...
...e United States,Agency for International Developme...Sur,Eau, a safe-water solution that reduces the ri...lution that prevents waterborne,diseases. The chlo...and AIDS -- from deadly diarrheal diseases., Acro...
... Golf greats competing in the,annual Liberty Mutua... will,be able to watch and participate in demonstr...at Golfest hosted in conjunction with the tourname...al,s da Vinci S Surgical System., In the last 20 ...
...has awarded TriWest Healthcare,Alliance in Phoenix...h,URAC,s high standards. TriWest administers the m...n beneficiaries in 21 western states., URAC exami...ntact center, training, legal and data management ...
... popular eye surgery, but complaints show it may n...ealthDay News) -- Golf great Tiger Woods lauds vis...ASA now allows astronauts to undergo the procedure...this elective surgery being lost in this laudatory...
... April 25 Today is a,great day for the people of ...rate. We celebrate because of the possibilities th... deaths, announced today by the United,Nations Sec...ions of lives will be saved in Africa and the worl...
Other Medicine News:Health News:Medarex and Bristol-Myers Squibb Joint Statement on Submission Status of Ipilimumab 2Health News:Medarex and Bristol-Myers Squibb Joint Statement on Submission Status of Ipilimumab 3Health News:Medarex and Bristol-Myers Squibb Joint Statement on Submission Status of Ipilimumab 4Health News:Medarex and Bristol-Myers Squibb Joint Statement on Submission Status of Ipilimumab 5Health News:Disinfecting Water Saves Lives in Rwanda 2Health News:Legends Golf Pros Receive Robotic Surgery Demos 2Health News:TriWest Earns URAC Health Network Reaccreditation 2Health News:FDA Examines 'Quality of Life' for LASIK Patients 2Health News:FDA Examines 'Quality of Life' for LASIK Patients 3Health News:Statement by H.E. Jakaya Mrisho Kikwete, President of the United Republic of Tanzania, and Chairman of the African Union, in Response to UN-SG Call to Action on Malaria 2
(Date:11/6/2009)...,, NATICK, Mass., Nov. 6 /PRNewswire-FirstCall/...day announced that it has reached an agreement in ...) related to product advisories issued by its Guid...roduct sales occurred prior to Boston Scientific,s...fic had previously disclosed an investigation by t...
(Date:11/6/2009)...,, SAN DIEGO, Nov. 6 ...hnology company focused on the development of smal... cancer and human immunodeficiency virus (HIV), to...results for the third quarter and nine months ende...ewscom.com/cgi-bin/prnh/20091104/ARDEALOGO ) ,,...
(Date:11/6/2009)...,, ATLANTA, Nov. 6 G...Vax" or "the Company"), an Atlanta-based, biopharm...seases caused by HIV-1 (Human Immunodeficiency Vir...ts third quarter 2009 financial results and provid....D., President and Chief Executive Officer comment...
Breaking Medicine Technology:Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 2Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 3Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 4Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 5Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 6Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 7Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 8Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 9Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 10Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 11Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 12Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 13Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 14Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 15Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 16Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 17Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8Assara Laser Announces Strategic Alliance with Park Avenue Laser Vision 59756 1Assara Laser Announces Strategic Alliance with Park Avenue Laser Vision 59756 2Assara Laser Announces Strategic Alliance with Park Avenue Laser Vision 59756 3CDPHP Launches National Network and Three In One Plan and Expands Member Incentives 59754 1CDPHP Launches National Network and Three In One Plan and Expands Member Incentives 59754 2CDPHP Launches National Network and Three In One Plan and Expands Member Incentives 59754 3CDPHP Launches National Network and Three In One Plan and Expands Member Incentives 59754 4Easy Way to Prevent Post Op Nausea 3F 59753 1Easy Way to Prevent Post Op Nausea 3F 59753 2
...e of Industry-Funded Immune Globulin Study Uncover...ne 26, 2007 /PRNewswire-USNewswire/ -- An analysis...try-sponsored,study ruling out a link between auti...of which contained the mercury-based,preservative ...alysis uncovered manipulation of the study sample,...
...he Netherlands, June 27, 2007-Organon, the human,h...oday that two,out of three Phase III clinical tria...ng-acting fertility hormone, have reached,their ra...new recombinant fertility hormone. It is,the first...icular,stimulant or SFS) of which, due to its long...
Other Medicine Technology:Genetics Journal Thimerosal/Autism Study the 'Best Science Drug,Company Money Can Buy' 2Genetics Journal Thimerosal/Autism Study the 'Best Science Drug,Company Money Can Buy' 3Two Phase III clinical trials on corifollitropin alfa (Org 36286),reach randomization target 2Two Phase III clinical trials on corifollitropin alfa (Org 36286),reach randomization target 3
Multi-Length Stent Sets - Sof-Flex®
Cook-Cope Loop Catheter Introduction Set
Percutaneous Entry Set
Movable Core Curved Safe-T-J® Wire Guides
Medicine Products: